Quetiapine Fumarate
Product Description
F.I.S. Fabbrica Italiana Sintetici SpA
-
IT -
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
F.I.S. Fabbrica Italiana Sintetici SpA
-
IT
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from F.I.S. Fabbrica Italiana Sintetici SpA (26)
-
Product Midazolam
FIS produces a wide range of API's which includes Midazolam. It is commercially available. Contact us for more information. -
Product Nitrazepam
FIS produces a wide range of API's which includes Nitrazepam. It is commercially available. Contact us for more information. -
Product Olopatadine Hydrochloride
FIS produces a wide range of API's which includes Olopatadine Hydrochloride. It is commercially available. Contact us for more information. -
Product Oxazepam
FIS produces a wide range of API's which includes Oxazepam. It is commercially available. Contact us for more information. -
Product Pentazocine
FIS produces a wide range of API's which includes Pentazocine. It is commercially available. Contact us for more information. -
Product Prazepam
FIS produces a wide range of API's which includes Prazepam. It is commercially available. Contact us for more information. -
Product Progesterone
FIS produces a wide range of API's which includes Progesterone. It is commercially available. Contact us for more information. -
Product Temazepam
FIS produces a wide range of API's which includes Temazepam. It is commercially available. Contact us for more information. -
Product Nitrofurantoin macrocrustals and monohydrate
FIS produces a wide range of API's which includes Nitrofurantoin macrocrystals and monohydrate. It is commercially available. Contact us for more information:[email protected] -
Product Diazepam
FIS produces a wide range of API's which includes Diazepam. It is commercially available. Contact us for more information:[email protected] -
Product Furosemide
FIS produces a wide range of API's which includes Furosemide. It is commercially available. Contact us for more information:[email protected]
F.I.S. Fabbrica Italiana Sintetici SpA resources (1)
-
News Revenues up 20% in 2022
The growth trend remains in the first quarter of 2023: revenues of €153 million, up 31% compared to the first quarter of 2022
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance